
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


We are facing issues. Price Chart is not available currently.
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
0 Cr
—
—
29.9
—
0.0
—
—
Sales CAGR
1Y
—
3Y
—
5Y
—
10Y
—
Profit CAGR
1Y
60.40%
3Y
—
5Y
—
10Y
—
ROE
TTM
-4.23%
3Y
-5.76%
5Y
-2.20%
10Y
5.96%
ROCE
TTM
-3.58%
3Y
-6.89%
5Y
-2.22%
10Y
9.90%
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Triochem Products Ltd (TRIPR) is currently trading at N/A per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Triochem Products Ltd, founded in 1972, is a manufacturer and exporter of pharmaceuticals, APIs, and chemicals. Despite the lack of recent investor presentations or concall transcripts, the company maintains a strong legacy in pharmaceutical manufacturing. Triochem's core focus is on APIs and chemicals, serving both domestic and international markets with its products. Their long-standing presence in the pharmaceutical sector showcases their continued commitment to quality manufacturing and exports.
Over the past 52 weeks, Triochem Products Ltd has traded between a low of ₹0.00 and a high of ₹0.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Triochem Products Ltd has a market capitalization of approximately 0.43. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Triochem Products Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
You can buy shares of Triochem Products Ltd (TRIPR) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.
Based on its market capitalization of 0.43 Cr, Triochem Products Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Triochem Products Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Triochem Products Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Triochem Products Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.
Key risks associated with Triochem Products Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.
Bearish
0
Neutral
9
Bullish
0
Bearish
0
Neutral
25
Bullish
0
Bearish
0
Neutral
16
Bullish
0
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
MODERATE MARGIN
Technicals
Neutral
Risk
MODERATE RISK
Market Cap
₹ 0 Cr
P/E
—